Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China

D Wang, B Hu, C Hu, F Zhu, X Liu, J Zhang, B Wang… - jama, 2020 - jamanetwork.com
Wang and Peng had full access to all of the data in the study and take responsibility for the
integrity of the data and the accuracy of the data … Wang contributed equally to this article. …

[HTML][HTML] Lycopene and risk of prostate cancer: a systematic review and meta-analysis

…, X Wang, K Zhao, DS Negi, L Zhuo, M Qi, X Wang… - Medicine, 2015 - journals.lww.com
Prostate cancer (PCa) is a common illness for aging males. Lycopene has been identified as
an antioxidant agent with potential anticancer properties. Studies investigating the relation …

Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)

…, X Wu, L Zhang, T He, H Wang, J Wan, X Wang… - JAMA …, 2020 - jamanetwork.com
Importance Increasing numbers of confirmed cases and mortality rates of coronavirus disease
2019 (COVID-19) are occurring in several countries and continents. Information regarding …

Antibacterial electrospun nanofibrous materials for wound healing

Z Wang, W Hu, W Wang, Y Xiao, Y Chen… - Advanced Fiber …, 2023 - Springer
One of the leading causes of wound healing delays is bacterial infection, which limits the
process of restoring the histological and functional integrity of the skin. Electrospun nanofibrous …

[HTML][HTML] Green tea and the risk of prostate cancer: A systematic review and meta-analysis

…, F Zhi, P Chen, K Zhao, H Xiang, Q Mao, X Wang… - Medicine, 2017 - journals.lww.com
Prostate cancer (PCa) now remains the 2nd most frequently diagnosed cancer. In recent
years, chemoprevention for PCa becomes a possible concept. Especially, many …

Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension …

…, ZG She, Y Wang, Q Xu, R Tan, H Wang… - Circulation …, 2020 - Am Heart Assoc
Rationale: Use of ACEIs (angiotensin-converting enzyme inhibitors) and ARBs (angiotensin
II receptor blockers) is a major concern for clinicians treating coronavirus disease 2019 (…

Favipiravir versus arbidol for COVID-19: a randomized clinical trial

…, Y Zhang, B Chen, M Lu, Y Luo, J Zhang, X Wang - MedRxiv, 2020 - medrxiv.org
Importance WHO has made the assessment that coronavirus disease 2019 (COVID-19) can
be characterized as a pandemic. So far, there is no clinically proven effective antiviral drug …

Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility

…, Y He, B Sun, M Wei, G Yang, X Wang… - Clinical Infectious …, 2021 - academic.oup.com
To explore any relationship between the ABO blood group and the coronavirus disease
2019 (COVID-19) susceptibility, we compared ABO blood group distributions in 2173 COVID-19 …

Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label …

…, B Wang, C Chen, Y Chen, X Song, Y Wang… - The Lancet Infectious …, 2021 - thelancet.com
Background SARS-CoV-2 has caused millions of deaths, and, since Aug 11, 2020, 20
intramuscular COVID-19 vaccines have been approved for use. We aimed to evaluate the safety …

Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation

…, Z Pan, Y Pan, Q Deng, L Chen, J Li, Y Li, X Wang - Journal of Infection, 2020 - Elsevier
Objectives Previous studies on the pneumonia outbreak caused by the 2019 novel coronavirus
disease (COVID-19) were based on information from the general population. However, …